Endoscopic removal of small rectal neuroendocrine tumors
Part of Cancer, Digestive system clinical trials.
This trial compares two minimally invasive methods to remove small rectal neuroendocrine tumors (less than 1 cm) during a colonoscopy. It may help patients avoid major surgery while still effectively treating the tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a rectal neuroendocrine tumor that looks typical on colonoscopy and is within 15 cm of the anal opening.
- The tumor is smaller than 1 cm (about the size of a pea) as seen on a colonoscopy.
- The tumor is only in the inner lining or just beneath it (not deep).
- You have no serious bleeding problems (normal blood clotting).
- You do not have severe heart or blood vessel disease that would make the procedure risky.
- There is no sign that the tumor has spread to other parts of the body.
- You have only one rectal neuroendocrine tumor (not two or more).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two minimally invasive endoscopic techniques—ESD and EPMR—for removing small neuroendocrine tumors (slow-growing hormone-producing tumors) in the rectum. The goal is to see which approach works better and is safer for patients.
This study looks at removing small rectal neuroendocrine tumors using an endoscope (a thin camera tool) instead of open surgery. It may help people with very small tumors if the doctors think you can safely have this procedure and the cancer has not spread to lymph nodes or distant organs.
This trial tests two endoscopic techniques (mEMR-C and mEMR-L) to remove small rectal neuroendocrine tumors. It may help patients with tumors 10 mm or smaller who want a less invasive treatment option.
This study compares two minimally invasive ways to remove small rectal neuroendocrine tumors (NETs), which are growths in the rectum that are usually not cancer. The goal is to find which method is safer and more effective with fewer side effects.
This trial tests whether removing lymph nodes in the pelvis during laparoscopic surgery for rectal neuroendocrine tumors (a type of slow-growing or aggressive tumor) improves outcomes. It is for people with larger or recurrent tumors, or those at higher risk due to tumor grade or depth.
This trial compares two procedures to remove large, non-cancerous growths from the lower rectum. It aims to see which method is safer and more effective for patients with these specific types of growths.
Hear when a new Rectal Neuroendocrine Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.